Cite
Evers A, Haack T, Lorenz M, et al. Correction to Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonist. J Med Chem. 2017;60(13):5941doi: 10.1021/acs.jmedchem.7b00887.
Evers, A., Haack, T., Lorenz, M., Bossart, M., Elvert, R., Henkel, B., Stengelin, S., Kurz, M., Glien, M., Dudda, A., Lorenz, K., Kadereit, D., & Wagner, M. (2017). Correction to Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonist. Journal of medicinal chemistry, 60(13), 5941. https://doi.org/10.1021/acs.jmedchem.7b00887
Evers, Andreas, et al. "Correction to Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonist." Journal of medicinal chemistry vol. 60,13 (2017): 5941. doi: https://doi.org/10.1021/acs.jmedchem.7b00887
Evers A, Haack T, Lorenz M, Bossart M, Elvert R, Henkel B, Stengelin S, Kurz M, Glien M, Dudda A, Lorenz K, Kadereit D, Wagner M. Correction to Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonist. J Med Chem. 2017 Jul 13;60(13):5941. doi: 10.1021/acs.jmedchem.7b00887. Epub 2017 Jul 05. PMID: 28677386.
Copy
Download .nbib